Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Female. Found 974 abstracts

no pagination
Cohen EE, Soulieres D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet (London, England). 2019 Jan 12;393(10167):156-67.
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019 Jan 05;393(10166):40-50.   PMCID: PMC6541928
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England journal of medicine. 2019 Jul 25;381(4):317-27.   PMCID: PMC6810605
Hellmann MD, Paz-Ares L, Bernabe Caro R, Zurawski B, Kim SW, Carcereny Costa E, Park K, Alexandru A, Lupinacci L, de la Mora Jimenez E, Sakai H, Albert I, Vergnenegre A, Peters S, Syrigos K, Barlesi F, Reck M, Borghaei H, Brahmer JR, O'Byrne KJ, Geese WJ, Bhagavatheeswaran P, Rabindran SK, Kasinathan RS, Nathan FE, Ramalingam SS. Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. The New England journal of medicine. 2019 Sep 28;381(21):2020-31.
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019 May 14;10(1):2157.   PMCID: PMC6517388
Jones CE, Hammer AM, Cho Y, Sizemore GM, Cukierman E, Yee LD, Ghadiali SN, Ostrowski MC, Leight JL. Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia (New York, NY). 2019 Jan;21(1):132-45.   PMCID: PMC6293034
Pei J, Zhao X, Patchefsky AS, Flieder DB, Talarchek JN, Testa JR, Wei S. Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience. Medicine. 2019 Jun;98(25):e16031.   PMCID: PMC6636967
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulieres D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. The New England journal of medicine. 2019 Mar 21;380(12):1116-27.
Schwartz LA, Henry-Moss D, Egleston B, Patrick-Miller L, Markman E, Daly M, Tuchman L, Moore C, Rauch PK, Karpink K, Sands CB, Domchek SM, Bradbury AR. Preventative Health and Risk Behaviors Among Adolescent Girls With and Without Family Histories of Breast Cancer. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2019 Jan;64(1):116-23.
Amin A, Plimack ER, Ernstoff MS, Lewis LD, Bauer TM, McDermott DF, Carducci M, Kollmannsberger C, Rini BI, Heng DY, Knox J, Voss MH, Spratlin J, Berghorn E, Yang L, Hammers HJ. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Journal for immunotherapy of cancer. 2018 Oct 22;6(1):109.   PMCID: PMC6196426
Bartel MJ, Puri R, Brahmbhatt B, Chen WC, Kim D, Simons-Linares CR, Stauffer JA, Buchanan MA, Bowers SP, Woodward TA, Wallace MB, Raimondo M, Asbun HJ. Endoscopic and surgical management of nonampullary duodenal neoplasms. Surgical endoscopy. 2018 Jun;32(6):2859-69.
Bass SB, Jessop A, Maurer L, Gashat M, Al Hajji M, Gutierrez M. Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development. Journal of health communication. 2018 Jan;23(1):117-27.
Collins BN, Lepore SJ, Winickoff JP, Nair US, Moughan B, Bryant-Stephens T, Davey A, Taylor D, Fleece D, Godfrey M. An Office-Initiated Multilevel Intervention for Tobacco Smoke Exposure: A Randomized Trial. Pediatrics. 2018 Jan;141(Suppl 1):S75-s86.   PMCID: PMC5745677 conflicts of interest to disclose.
Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DP, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. The New England journal of medicine. 2018 Feb 22;378(8):731-9.   PMCID: PMC5857389
Gettinger S, Hellmann MD, Chow LQ, Borghaei H, Antonia S, Brahmer JR, Goldman JW, Gerber DE, Juergens RA, Shepherd FA, Laurie SA, Young TC, Li X, Geese WJ, Rizvi N. Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC. J Thorac Oncol. 2018 Sep;13(9):1363-72.
Geynisman DM, Meeker CR, Doyle JL, Handorf EA, Bilusic M, Plimack ER, Wong YN. Provider and patient burdens of obtaining oral anticancer medications. The American journal of managed care. 2018 Apr;24(4):e128-e133.
Handra-Luca A, Wei S. Intrathyroid cystic thyroglossal duct remnant and ectopic thymus: a fortuitous or development-related association?. Surgery today. 2018 Aug;48(8):815-8.
Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis. Eur Urol. 2018 Sep;74(3):387-93.
Lamb EP, Pritchard FE, Nouer SS, Tolley EA, Boyd BS, Davidson JT, Munene G, Fleming MD. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018 May;84(5):620-7.
Lee MH, Chakhtoura M, Sriram U, Caricchio R, Gallucci S. Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. Journal of immunology research. 2018 Apr;2018:1601079.   PMCID: PMC5925037
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Female

Female Male Middle Aged Adult Aged therapeutic use drug therapy 80 and over Aged pathology genetics administration & dosage adverse effects mortality Antineoplastic Agents Retrospective Studies Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols metabolism Kidney Neoplasms therapy Young Adult surgery Adolescent Renal Cell Carcinoma Mice Local Neoplasm Recurrence Nivolumab secondary methods Health Services Accessibility Pyrimidines Registries Treatment Outcome Transgenic Mice Child Sunitinib Progression-Free Survival Cetuximab immunology Lung Neoplasms Squamous Cell Carcinoma of Head and Neck Non-Small-Cell Lung Carcinoma antagonists & inhibitors Monoclonal Antibodies-Humanized statistics & numerical data pharmacology Inbred C57BL Mice diagnosis Drug Administration Schedule Time Factors Head and Neck Neoplasms psychology Healthcare Disparities Protein Kinases virology Tyrosine kinase inhibitor Patient Compliance Thyroid Diseases Granulocyte-Macrophage Colony-Stimulating Factor MicroRNAs Receptor Protein-Tyrosine Kinases Ductal Carcinoma-Breast Proto-Oncogene Proteins BRCA 2 protein Pennsylvania Dendritic Cells Ambulatory Care Lobular Carcinoma Mothers Immune checkpoint inhibitor Digestive System Endoscopy Surgical resection Smoking Cessation Prior Authorization 4 Phosphatidylinositol-3-5-Trisphosphate 5-Phosphatases Intention to Treat Analysis Socioeconomic Factors Skin Neoplasms Nonampullary duodenal neoplasms Chemoradiotherapy Tobacco Smoke Pollution Programmed death 1 axis inhibitor Oropharyngeal Neoplasms Survival Analysis Extracellular Matrix Soft Tissue Neoplasms Cysts Disease Progression Maintenance Chemotherapy Hepatitis C Cisplatin Fibroblasts Maternal behavior Breast Neoplasms High-Volume Hospitals Hbme1 Preschool Child CD8-Positive T-Lymphocytes Tennessee Infant Duodenal Neoplasms Healthy lifestyle transplantation Carcinoma Opiate Substitution Treatment Transcriptome CD138 Intravenous Administration Piperazines Environmental Pollution Cyst Animal Mammary Glands Pharmaceutical Services Insurance Metastatic renal cell carcinoma Pancreatic Neoplasms B7-H1 Antigen Lupus Nephritis Renal cell carcinoma Tumor Biomarkers Animal Disease Models Counseling Length of Stay Parathyroid Glands Pazopanib Sarcoma Prostatic Neoplasms Intraductal Carcinoma-Noninfiltrating Follow-Up Studies Endoscopic Mucosal Resection Intensity-Modulated Radiotherapy Patient Education as Topic cytology BRCA1 protein Estradiol Experimental Melanoma adverse Tobacco Smoking Cancer survival Health Status Disparities Neoplastic Gene Expression Regulation Thyroid Adenocarcinoma Oral Administration Polycomb Repressive Complex 2 Double-Blind Method Phthalazines Sulfonamides Thymus Gland effects Papillomavirus Infections
Last updated on Friday, December 06, 2019